share_log

aTyr Pharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

SEC ·  Mar 7, 2023 21:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more